Navigation Links
EaglePicher Technologies Introduces First Implantable Medical Cell Designed Specifically for Monitoring Applications
Date:1/29/2008

Lithium Thionyl chloride cells provide high energy density and low entry

cost

JOPLIN, Mo., Jan. 29 /PRNewswire/ -- EaglePicher Technologies, LLC, an EaglePicher company, today announced its Medical Power group introduced two new implantable medical batteries to the market. The two batteries, aimed at the rapidly growing implantable monitor market, provide high energy density and low entry cost. Typical applications include implantable cardiac and glucose monitors.

The two Lithium Thionyl chloride cells, available in 350 mAh and 750mAh formats, join the EaglePicher Medical Power CONTEGO Modular Battery Line. Lithium Thionyl chloride is characterized by a high energy density and low self discharge for maximum reliability.

The cells are fully qualified for implantable applications, manufactured in the United States and available immediately. The CONTEGO series of modular implantable batteries is available in a range of capacities from 500uAh to 3.5Ah.

"Wireless devices are becoming an accepted method for monitoring the body prior to implanting expensive pacing devices or performing cardiac surgery," said Clay Braziller, director of Sales and Marketing, EaglePicher Technologies/Medical Power. "EaglePicher's new Lithium Thionyl chloride cells, with their low cost, low weight and high capacity, are a perfect match for monitoring applications and have already attracted several global customers."

To download a high resolution photo of the new cells, please visit http://www.eaglepicher.com/EaglePicherInternet/Companies/EaglePicher+Medica l+P ower/News/ . (Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

EaglePicher Technologies, LLC, an EaglePicher company, is the leading producer of batteries and energetic devices for the defense, space and commercial industries, and provides the most experience and broadest capability in battery electrochemistry of any battery supplier in the United States. EaglePicher Technologies offers a wide range of battery technology including thermal, nickel hydrogen, lithium carbonmonofluoride, lithium thionyl chloride, lithium manganese dioxide, lithium sulfur dioxide, lithium ion, reserve lithium oxyhalide, custom battery assemblies and silver zinc batteries. It also provides other energy products and pyrotechnic devices for the defense industry, as well as advanced battery chargers and other power solutions for business, industrial and recreational applications. EaglePicher Technologies is headquartered in Joplin, Mo., and is an AS9100 certified supplier. For more information, visit http://www.eaglepicher.com.

About EaglePicher Medical Power

EaglePicher Medical Power is a world-leading supplier of batteries to manufacturers of implantable medical devices. Products include batteries for cardio defibrillators, heart monitors, heart re-synchronizers and neuromodulation systems.

EaglePicher Medical Power is one of the few producers of implantable-grade batteries in the world to be certified ISO 13485, and leads the industry in producing rechargeable lithium-ion batteries for implantable applications.

Building upon the world-class technology heritage of parent EaglePicher, the company offers one of the broadest ranges of electrochemistries for implantable applications including lithium-ion, lithium manganese dioxide, lithium thionyl chloride and lithium carbon monofluoride.


'/>"/>
SOURCE EaglePicher Technologies, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
2. China Medical Technologies to Announce Financial Results for the Third Quarter Ended December 31, 2007 on February 28, 2008
3. Companys Award-Winning Sound Enhancement Technology Proven to Provide Superior Performance Over Other Technologies; Patent Will Enhance Able Planet, LINX AUDIO Brands
4. ImmunoVaccine Technologies Receives $3 Million From ACOA
5. National report calls for more research on health effects of wireless technologies
6. VNUS Medical Technologies Appoints Peter Osborne as Chief Financial Officer
7. ReBuilder Medical Technologies, Inc. Expands R&D of New Products
8. Global Med Technologies(R) Adds Eighth SafeTrace Tx(R) Client in New York State
9. ReBuilder Medical Technologies, Inc. Announces Televised Broadcast
10. OneMedPlace Emerging Healthcare Technologies Finance Forum Jan 7, 8th
11. ReBuilder Medical Technologies, Inc. 4th Quarter Sales Increase 100% Exceeding Projections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... Antonio, TX (PRWEB) , ... February 12, 2016 , ... ... love, as expressed in Blue SKies Buddha, the biography of Rama - Dr. Frederick ... fact a love story, the love of a Buddhist teacher for teaching and helping ...
(Date:2/12/2016)... ... February 12, 2016 , ... The Lymphoma Research ... lymphoma research and serving the lymphoma community through a comprehensive series of education ... Florida’s philanthropic community at its 10th anniversary Fashion Luncheon on Monday, February 8, ...
(Date:2/12/2016)... Middletown, PA (PRWEB) , ... February 12, 2016 , ... ... year’s event will be held in Anaheim, CA at the Anaheim Convention Center. Almost ... they can see new therapy products in action, learn more about their chosen field ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... ... firm announced that nominations have closed for the ISE Southeast Awards 2016. Finalists ... be announced at the ISE® Southeast Executive Forum and Awards Gala on March ...
(Date:2/12/2016)... ... 12, 2016 , ... Every winter, someone is killed, injured or loses a ... Burn Center, part of the Allegheny Health Network, has partnered with Etna Volunteer ... Heaters Need Space” campaign. , “Space Heaters Need Space” aims to bring ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... 12, 2016  Apellis Pharmaceuticals, Inc., today ... million Series D preferred stock financing, co-led ... Capital Group and venBio Global Strategic Fund, ... IB Investment, and Epidarex Capital. The proceeds of ... advance clinical trials in the Company,s ongoing ...
(Date:2/12/2016)... February 12, 2016 ... titled Chronic Inflammation Global Clinical Trials Review, H2, ... the global clinical trials landscape along with top ... Region, Country (G7 & E7), Trial Status, Trial ... reviews top companies involved and enlists all trials ...
(Date:2/11/2016)... , Feb. 11, 2016 The primary ... and future adoption patterns on the usage of liquid ... the following: - Timeframe of liquid biopsy ... ctDNA, cfDNA and Evs—by organization type - Sample inflow ... types: blood, saliva, stool, serum, and so on. - ...
Breaking Medicine Technology: